Best Bets for april 8

Although there is no cure, researchers say they have never had a better understanding of the mechanisms responsible for tinnitus.

Mon, Mar 31, 2008 (7:17 p.m.) Two big studies offer good news to people with high blood pressure, finding that novel ways to use cheap drugs already on the market can lower their risk of heart attacks, stroke and death _ even if they are very old.

CHICAGO -- Two big studies offer good news to people with high blood pressure, finding that novel ways to use cheap drugs already on the market can lower their risk of heart attacks,...

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have found post-traumatic stress disorder (PTSD) is associated with more hospitalizations, longer hospitalizations and greater mental healthcare utilization in urban primary care patients.

Two big studies offer good news to people with high blood pressure, finding that novel ways to use cheap drugs already on the market can lower their risk of heart attacks, stroke and death — even if they are very old.

Thousands of Australians will benefit from a range of drugs newly available on the Pharmaceutical Benefits Scheme.

Two big studies offer good news to people with high blood pressure, finding that novel ways to use cheap drugs already on the market can lower their risk of heart attacks, stroke and death - even if they are very old. Both studies were stopped early so the surprising benefits could be made known. Doctors presented results Monday at an American College of Cardiology conference in Chicago. "It is ...

West Tennessee-National Fibromyalgia/Chronic Fatigue Group meets at 1 p.m. today at the Medical Center Laboratory on West Forest Ave., across the street from Jackson-Madison County General Hospital.

MOUNTAIN VIEW, Calif. ( Map ) - MOUNTAIN VIEW , Calif., March 31 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that it has obtained a committed equity financing facility under which it may sell up to $50 million of its registered common stock to Azimuth Opportunity, Ltd. over a 24-month period.